C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
12/2009
12/17/2009	US20090312524 Compositions and methods comprising collagen
12/17/2009	US20090312523 Methods and apparatus for continuous large-scale radiolabeling
12/17/2009	US20090312259 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
12/16/2009	CN101601986A Preparation method of chitosan-silicon dioxide compound hollow microballoon and application thereof
12/15/2009	US7632927 comprises an alpha-emitter (e.g. Bi-213) bound to the monoclonal antibody C595 by a chelating agent selected from DOTA, cDTPA, DTPA-CHX-A or TETA; anticarcinogenic agent particularly efficient for treatment of pancreatic and prostate cancer, as well as for breast and ovarian cancer
12/15/2009	US7632922 Osteoprotegerin
12/15/2009	US7632646 Tuberculosis diagnostic test
12/15/2009	US7632618 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/15/2009	US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009	US7632507 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders
12/15/2009	US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009	CA2294996C Angiotensin derivatives
12/10/2009	US20090305986 FGF21 Mutants and uses thereof
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	CA2726942A1 Fviii muteins for treatment of von willebrand disease
12/09/2009	EP2129692A2 Activation of human antigen-presenting cells through clec-6
12/09/2009	EP1112274B1 Chemiluminescent 1,2-dioxetanes
12/09/2009	CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
12/09/2009	CN100567488C Enhancement of virus-mediated DNA transfer
12/08/2009	US7629172 Mutant binding protein containing reporter molecules; monitoring glucose concentration; quantitative analysis
12/08/2009	US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
12/08/2009	US7629134 Sour taste receptor compositions and methods
12/08/2009	US7628986 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
12/03/2009	WO2009143565A1 Method of diagnosis of infection by mycobacteria and reagents therefor
12/03/2009	US20090298199 Immunosorbent assay support and method of use
12/03/2009	US20090298154 Conjugated biological molecules and their preparation
12/03/2009	CA2725613A1 Method of diagnosis of infection by mycobacteria and reagents therefor
12/02/2009	EP2128616A1 Support having protein immobilized thereon and method of producing the same
12/02/2009	EP2128272A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
12/02/2009	EP2125911A2 Surface-bound fluorinated esters for amine capture
12/02/2009	EP2124906A1 Polypeptide films and methods
12/02/2009	EP2124548A2 Disintegrin variants and pharmaceutical uses thereof
12/02/2009	CN101595132A Use of thermostable biotin-binding protein and solid support having the protein bound thereto
12/01/2009	US7625999 Immobilization on solid support
12/01/2009	US7625564 Immunoglobulins; immunogens
12/01/2009	CA2316894C Polysaccharide conjugate capable of binding cellulose
11/2009
11/26/2009	WO2009143008A1 Solubilization of proteins in reverse micelles by extraction from a solid support
11/26/2009	WO2009085096A3 Non-leaching, non-fouling antimicrobial coatings
11/26/2009	US20090292113 Recombinant soluble Fc receptors
11/26/2009	CA2725043A1 Solubilization of proteins in reverse micelles by extraction from a solid support
11/25/2009	EP2121764A1 Viral polyhedra complexes and methods of use
11/25/2009	CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/24/2009	US7622555 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease
11/24/2009	US7622553 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
11/24/2009	US7622269 Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
11/24/2009	US7622116 Method of treating inflammation using soluble IL-17RCX4
11/19/2009	WO2009079910A8 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof
11/19/2009	US20090286958 Interferon-beta fusion proteins and uses
11/19/2009	US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/18/2009	EP2118136A2 Consensus peptide
11/18/2009	EP2117575A2 Methods and compositions related to clot binding compounds
11/18/2009	EP1572961B1 Actriib fusion polypeptides and uses therefor
11/18/2009	CN101580585A Histidine selective water soluble polymer derivative
11/18/2009	CN101580547A HASylated polypeptides, especially HASylated erythropoietin
11/17/2009	US7619068 Antiovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo; detecting Ovr110 overexpression
11/17/2009	US7618941 Treating degenerative joint disorders with tribonectins
11/17/2009	US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/17/2009	CA2362878C N-[n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester agglomerate
11/12/2009	WO2009136186A1 Surfaces with immobilized enzymes or anti-icing proteins
11/12/2009	US20090280499 Method and kit for detecting, or determining 3,4- methylenedioxymethamphetamine
11/12/2009	US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals
11/12/2009	CA2720469A1 Surfaces with immobilized enzymes or anti-icing proteins
11/11/2009	EP2116604A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
11/11/2009	EP1869066B1 Peptide synthesis of alpha-helixes on peg resin
11/11/2009	CN101575378A Coupling reagent kit
11/11/2009	CN100558747C Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application
11/10/2009	US7615224 Multiplex-bead complex for determination of lysosomal storage disorders
11/05/2009	WO2009134977A1 Cross-linkers and their uses
11/05/2009	WO2009102782A3 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates
11/05/2009	US20090275721 Coating Surfaces
11/05/2009	US20090275066 Immobilization of membrane porteins onto supports via an amphiphile
11/05/2009	US20090274699 Ul16 binding protein 4
11/05/2009	CA2722696A1 Cross-linkers and their uses
11/04/2009	EP2113517A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
11/03/2009	US7612186 Compositions and methods for producing recombinant proteins
10/2009
10/29/2009	WO2009132037A1 ANTI-TNFα ANTIBODY
10/29/2009	WO2009131643A1 Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
10/29/2009	WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009	US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins
10/29/2009	CA2727973A1 Peptidyl diacylglycerides
10/29/2009	CA2721833A1 Prion epitopes and methods of use thereof
10/28/2009	EP2111426A1 Method of drying biological material
10/28/2009	EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009	EP1402016B1 Functionalized porous materials and applications in medical devices
10/28/2009	CN101565469A Acid amide-grafted sodium alginate nanometer material, preparation method thereof and use thereof
10/27/2009	US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009	US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009	US7608265 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile
10/27/2009	CA2162366C Conjugation-stabilized polypeptide compositions
10/27/2009	CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/22/2009	US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009	US20090263424 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/21/2009	EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/20/2009	US7605253 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
10/20/2009	US7605228 Insecticidal toxin complex fusion proteins
10/15/2009	WO2009126564A1 Methods of recombinant production of glycoproteins
10/15/2009	US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009	US20090258381 Methods for Determining the Cleavability of Substrates
10/15/2009	US20090258029 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/13/2009	US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy

1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 107